Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Triclabendazole

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 63Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Alivira Animal Health
    India
    		 ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam IN CEP 2023-358 - Rev 00 Triclabendazole for veterinary use, Process-II 2024-09-23 Valid Chemical 2609
    28/10/2024 Alivira Animal Health
    India
    		 ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam IN R1-CEP 2015-109 - Rev 02 Triclabendazole for veterinary use 2023-07-03 Valid Chemical 2609